APA (7th ed.) Citation

JP, F., JP, B., JR, T., MN, K., CE, A., J, B., . . . AA, V. (2023). Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSE. European journal of heart failure, 25(10), 1797. https://doi.org/10.1002/ejhf.2982

Chicago Style (17th ed.) Citation

JP, Ferreira, et al. "Mineralocorticoid Receptor Antagonist Use and the Effects of Empagliflozin on Clinical Outcomes in Patients Admitted for Acute Heart Failure: Findings from EMPULSE." European Journal of Heart Failure 25, no. 10 (2023): 1797. https://doi.org/10.1002/ejhf.2982.

MLA (9th ed.) Citation

JP, Ferreira, et al. "Mineralocorticoid Receptor Antagonist Use and the Effects of Empagliflozin on Clinical Outcomes in Patients Admitted for Acute Heart Failure: Findings from EMPULSE." European Journal of Heart Failure, vol. 25, no. 10, 2023, p. 1797, https://doi.org/10.1002/ejhf.2982.